Table of Content

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Myasthenia Gravis Treatment Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Myasthenia Gravis Treatment Market Analysis
4.1. Market Portraiture
4.2. Market Drug Class
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Myasthenia Gravis Treatment Market by Drug Class
5.1. Introduction
5.2. Intravenous Immunoglobulin
5.3. Monoclonal Antibodies
5.4. Cholinesterase Inhibitors
5.5. Other Drugs
6. Global Myasthenia Gravis Treatment Market by Age Group
6.1. Introduction
6.2. Below 55 Years
6.3. Above 55 Years
7. Global Myasthenia Gravis Treatment Market by End-Use
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Drug Store and Retail Pharmacies
7.4. Online Providers
8. Global Myasthenia Gravis Treatment Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Astellas Pharma Inc.
12.2.2. AstraZeneca
12.2.3. Bausch Health Companies, Inc.
12.2.4. CSL Limited
12.2.5. F. Hoffmann-La Roche Ltd.
12.2.6. Grifols, S.A.
12.2.7. Kedrion, SpA
12.2.8. Novartis AG
12.2.9. Octapharma AG
12.2.10. Stryker Corporation
12.2.11. Veloxis Pharmaceuticals Inc.
12.2.12. Zydus Lifesciences Limited

?
List of Figures

Figure 1: Global Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 2: Global Myasthenia Gravis Treatment Market by Drug Class, 2023
Figure 3: Global Myasthenia Gravis Treatment Market by Age Group, 2023
Figure 4: Global Myasthenia Gravis Treatment Market by End-Use, 2023
Figure 5: Global Myasthenia Gravis Treatment Market by Region, 2023
Figure 6: Global Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 7: Global Myasthenia Gravis Treatment Market by Drug Class (in %), 2023 & 2033
Figure 8: Global Intravenous Immunoglobulin Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 9: Global Intravenous Immunoglobulin Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 10: Global Monoclonal Antibodies Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 11: Global Monoclonal Antibodies Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 12: Global Cholinesterase Inhibitors Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 13: Global Cholinesterase Inhibitors Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 14: Global Other Drugs Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 15: Global Other Drugs Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 16: Global Myasthenia Gravis Treatment Market by Age Group (in %), 2023 & 2033
Figure 17: Global Below 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 18: Global Below 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 19: Global Above 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 20: Global Above 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 21: Global Myasthenia Gravis Treatment Market by End-Use (in %), 2023 & 2033
Figure 22: Global Hospital Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 23: Global Hospital Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 24: Global Drug Store and Retail Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 25: Global Drug Store and Retail Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 26: Global Online Providers Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 27: Global Online Providers Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 28: Global Myasthenia Gravis Treatment Market by Region (in %), 2023 & 2033
Figure 29: Europe Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 30: Europe Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 31: Europe Myasthenia Gravis Treatment Market by Country (in %), 2023 & 2033
Figure 32: Germany Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 33: United Kingdom Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 34: France Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 35: Italy Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 36: Spain Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 37: Russia Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 38: Netherlands Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 39: North America Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 40: North America Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 41: North America Myasthenia Gravis Treatment Market by Country (in %), 2023 & 2033
Figure 42: United States Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 43: Canada Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 44: Asia Pacific Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 45: Asia Pacific Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 46: Asia Pacific Myasthenia Gravis Treatment Market by Country (in %), 2023 & 2033
Figure 47: China Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 48: Japan Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 49: India Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 50: South Korea Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 51: Australia Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 52: Indonesia Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 53: Latin America Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 54: Latin America Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 55: Latin America Myasthenia Gravis Treatment Market by Country (in %), 2023 & 2033
Figure 56: Mexico Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 57: Brazil Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 58: Argentina Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 59: Middle East & Africa Myasthenia Gravis Treatment Market (in US$ Million), 2019-2023
Figure 60: Middle East & Africa Myasthenia Gravis Treatment Market (in US$ Million), 2024-2033
Figure 61: Middle East & Africa Myasthenia Gravis Treatment Market by Country (in %), 2023 & 2033
Figure 62: Saudi Arabia Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 63: Turkey Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 64: Iran Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 65: UAE Myasthenia Gravis Treatment Market (in US$ Million), 2019-2033
Figure 66: Market Value Chain


List of Tables

Table 1: Global Myasthenia Gravis Treatment Market Portraiture
Table 2: Global Myasthenia Gravis Treatment Market by Drug Class (in US$ Million), 2023 & 2033
Table 3: Global Myasthenia Gravis Treatment Market by Age Group (in US$ Million), 2023 & 2033
Table 4: Global Myasthenia Gravis Treatment Market by End-Use (in US$ Million), 2023 & 2033
Table 5: Global Myasthenia Gravis Treatment Market by Region (in US$ Million), 2023 & 2033
Table 6: Europe Myasthenia Gravis Treatment Market by Country (in US$ Million), 2023 & 2033
Table 7: North America Myasthenia Gravis Treatment Market by Country (in US$ Million), 2023 & 2033
Table 8: Asia Pacific Myasthenia Gravis Treatment Market by Country (in US$ Million), 2023 & 2033
Table 9: Latin America Myasthenia Gravis Treatment Market by Country (in US$ Million), 2023 & 2033
Table 10: Middle East & Africa Myasthenia Gravis Treatment Market by Country (in US$ Million),
2023 & 2033
Table 11: List of Key Players